Calliditas Therapeutics
Biopharma company developing and commercializing treatments for rare diseases.
CALTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010441584 (+1 more)
- LEI:
- 549300PVPZO8TNT76B58
- Country:
- Sweden
- Address:
- Box 70351, 107 24 Stockholm
- Website:
- https://www.calliditas.se/en/
- Sector:
- Manufacturing
Description
Calliditas Therapeutics is a commercial-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for rare diseases with significant unmet medical needs. The company concentrates on orphan indications, with an initial focus on renal and hepatic diseases. Its lead product, TARPEYO® (budesonide), is approved in the U.S. for the treatment of primary immunoglobulin A nephropathy (IgAN) and is marketed as Kinpeygo® in Europe. Calliditas is advancing a pipeline of novel medications and seeks strategic partnerships to expand its development and commercialization efforts for therapies addressing conditions with few or no existing approved treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-30 14:30 |
Kommuniké från extra bolagsstämman i Calliditas Therapeutics AB (publ)
|
Swedish | 121.2 KB | ||
| 2024-09-16 15:30 |
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
English | 134.8 KB | ||
| 2024-09-16 15:30 |
Avnotering av Calliditas Therapeutics AB (publ) från Nasdaq Stockholm
|
Swedish | 134.6 KB | ||
| 2024-09-13 10:00 | Swedish | 14.6 KB | |||
| 2024-09-03 13:21 | Swedish | 13.9 KB | |||
| 2024-09-03 13:18 | Swedish | 13.4 KB | |||
| 2024-09-03 12:15 |
Calliditas Therapeutics takes certain corporate actions following announcement …
|
English | 130.9 KB | ||
| 2024-09-03 12:00 |
Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
|
English | 150.7 KB | ||
| 2024-09-03 10:57 | Swedish | 14.2 KB | |||
| 2024-08-13 07:00 | Swedish | 2.0 MB | |||
| 2024-08-13 07:00 | English | 2.0 MB | |||
| 2024-08-06 11:00 | English | 34.7 KB | |||
| 2024-08-05 13:51 | English | 34.5 KB | |||
| 2024-07-31 14:00 |
Antal aktier och röster i Calliditas Therapeutics
|
Swedish | 180.0 KB | ||
| 2024-07-31 14:00 |
Number of shares and votes in Calliditas Therapeutics
|
English | 120.7 KB |
Automate Your Workflow. Get a real-time feed of all Calliditas Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Calliditas Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Calliditas Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Diane Parks | Other | Other | 4,086 | N/A |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 36,000 | 7,408,800.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 31,439 | 6,476,434.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Buy | 40,939 | N/A |
| 2024-07-03 | Frank Bringstrup | Other | Sell | 8,000 | 1,646,400.00 SEK |
| 2024-07-02 | Richard Philipson | Other | Sell | 27,209 | 5,591,177.41 SEK |
| 2024-07-02 | Frank Bringstrup | Other | Sell | 9,796 | 2,012,980.04 SEK |
| 2024-07-02 | Sandra Boström Frithiof | Other | Sell | 6,530 | 1,341,849.70 SEK |
| 2024-07-01 | Richard Philipson | Other | Sell | 23,676 | 4,866,838.56 SEK |
| 2024-07-01 | Frank Bringstrup | Other | Sell | 8,523 | 1,751,987.88 SEK |
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
